Research using the human AML cell lines HL60 and THP-1, as well as the murine AML model expressing the MLL-AF9 fusion gene, revealed that interleukin 6 (IL6) promotes chemoresistance by enhancing MFN1-mediated mitochondrial fusion and boosting OXPHOS [129]. This evidence concerns the gene IL6 and acute myeloid leukemia.